Inspire Medical Systems (INSP) Tops Q4 EPS by 43c, provides guidance

Inspire Medical Systems (NYSE: INSP) reported Q4 EPS of $1.15, $0.43 better than the analyst estimate of $0.72. Revenue for the quarter came in at $239.72 million versus the consensus estimate of $233.03 million.

GUIDANCE:

Inspire Medical Systems sees FY2025 EPS of $2.10-$2.20, versus the consensus of $1.94. Inspire Medical Systems sees FY2025 revenue of $940-955 million, versus the consensus of $948.7 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• BTIG Upgrades Tidewater Inc (TDW) to Buy, 'Increasing Activity Set To Push Dayrates Higher in Key Basins'
• Sphere Entertainment (SPHR) Reiterated at Market Outperform by Citizens: Global Expansion Apace